AtriCure Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to AtriCure Reports Second Quarter 2016 Financial Results
August 5, 2016 8:34 AM EDT
Needham & Company maintained a Buy rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $20.00 (from $23.00), following the company's 2Q earnings report. Revenue was reported at $39.7M, a slight beat to the consensus estimate of $39.8M. EPS was ($0.26), ahead of consensus of ($0.30). ATRC lowered its... More
August 5, 2016 8:27 AM EDT
Piper Jaffray analyst Brooks West cut his price target on AtriCure Inc. (NASDAQ: ATRC) to $17.00 (from $22.00) following Q2 results, but maintained an Overweight rating saying guidance reset could be a positive clearing event.
West commented, "AtriCure reported 2Q16 revenues of $39.7M (+21.5% cc) vs. consensus of... More
August 4, 2016 5:16 PM EDT
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $39.7 million versus the consensus estimate of $39.84 million.
"We are pleased to report second quarter results which reflect many accomplishments we launched two new... More
